These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 1335812)
1. 2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis. Geier SA; Klauss V; Matuschke A; Kronawitter U; Goebel FD Ger J Ophthalmol; 1992; 1(2):110-3. PubMed ID: 1335812 [TBL] [Abstract][Full Text] [Related]
2. Foscarnet treatment in various cytomegalovirus infections. Brockmeyer NH; Hengge UR; Mertins L; Malessa R; Steinmetz R; Gooss M Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):204-7. PubMed ID: 8388868 [TBL] [Abstract][Full Text] [Related]
3. Zidovudine and cytomegalovirus retinitis. Carter JE; Shuster AR Ann Ophthalmol; 1992 May; 24(5):186-9. PubMed ID: 1322108 [TBL] [Abstract][Full Text] [Related]
4. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522 [TBL] [Abstract][Full Text] [Related]
5. [Cytomegalovirus retinitis in AIDS. Effectiveness and complications of long-term therapy]. Schmitz K; Fabricius EM; Popescu M Ophthalmologe; 1992 Oct; 89(5):416-26. PubMed ID: 1338968 [TBL] [Abstract][Full Text] [Related]
6. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Flores-Aguilar M; Kuppermann BD; Quiceno JI; Dankner WM; Wolf DG; Capparelli EV; Connor JD; Sherwood CH; Fullerton S; Gambertoglio JG Ophthalmology; 1993 Jul; 100(7):1022-31. PubMed ID: 8391674 [TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet. Patel SS; Rutzen AR; Marx JL; Thach AB; Chong LP; Rao NA Ophthalmology; 1996 Sep; 103(9):1476-82. PubMed ID: 8841309 [TBL] [Abstract][Full Text] [Related]
8. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Jabs DA Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191 [TBL] [Abstract][Full Text] [Related]
9. [Treatment with intravitreous ganciclovir in cytomegalovirus retinitis associated with AIDS]. Gutiérrez A; Martín I; Ferrer E; Torrón C; Aguirre JM Enferm Infecc Microbiol Clin; 1992 Dec; 10(10):629-30. PubMed ID: 1337981 [No Abstract] [Full Text] [Related]
10. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989 [TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus retinitis complicated by optic neuropathy: a longitudinal study. Harkins T; Maino JH J Am Optom Assoc; 1992 Jan; 63(1):21-7. PubMed ID: 1316391 [TBL] [Abstract][Full Text] [Related]
13. [Follow-up and long-term treatment of infections caused by human cytomegalovirus in 3 patients with AIDS]. Tinelli M; Parea M; Maccabruni A; Tacconi F Recenti Prog Med; 1991 Jun; 82(6):315-8. PubMed ID: 1656492 [TBL] [Abstract][Full Text] [Related]
14. Ocular manifestations of HIV infection. Jabs DA Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695 [TBL] [Abstract][Full Text] [Related]
15. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847 [TBL] [Abstract][Full Text] [Related]
16. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group. Parente F; Bianchi Porro G Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631 [TBL] [Abstract][Full Text] [Related]
17. Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). Polis MA; deSmet MD; Baird BF; Mellow S; Falloon J; Davey RT; Kovacs JA; Palestine AG; Nussenblatt RB; Masur H Am J Med; 1993 Feb; 94(2):175-80. PubMed ID: 8381583 [TBL] [Abstract][Full Text] [Related]
18. Ganciclovir: approved and investigational uses for the treatment of cytomegalovirus retinitis. MacArthur RB Mt Sinai J Med; 1990 Nov; 57(6):378-80. PubMed ID: 1964198 [No Abstract] [Full Text] [Related]
19. Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitis. Aweeka FT; Gambertoglio JG; Kramer F; van der Horst C; Polsky B; Jayewardene A; Lizak P; Emrick L; Tong W; Jacobson MA Clin Pharmacol Ther; 1995 Apr; 57(4):403-12. PubMed ID: 7712668 [TBL] [Abstract][Full Text] [Related]
20. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]